Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Medical Dermatology Challenge: Complex Cases

Description

In this presentation, a medical dermatologist discusses complex cases, sharing insights from his career and teaching experiences. He recounts two specific cases: one involving a patient with dermatomyositis whose real diagnosis was discovered to be a rare infection caused by Strongyloides after a misdiagnosis, highlighting the challenges of diagnosing infectious diseases that can hide for years, especially in immunocompromised patients. Strongyloides hyperinfection, exacerbated by steroid use, can lead to severe complications and has a significant mortality rate. The second case involves the diagnosis of necrolytic acrylate erythema, which was mistaken for a nutritional disorder in an overweight patient. The presentation explains the distinction between this and similar conditions such as necrolytic migratory erythema, particularly in relation to autoimmune diseases like hepatitis C. The speaker emphasizes the importance of careful diagnosis, mentioning the potential complications associated with misdiagnosing dermatological conditions and the significance of kindness in patient care. The talk underscores the evolving landscape of medical dermatology and the essential role of education and mentorship in developing skills to handle such complex cases.

View more

Conclusions

  • Dermatomyositis can lead to Strongyloidiasis infections as a complication of steroid management.
  • Patients with unrecognized Strongyloidiasis may present with abdominal pain and dynamic ileus after slight increases in steroids.
  • Strongyloidiasis has a significant mortality rate and should be considered in patients with ambiguous symptoms and history.
  • Necrolytic acral erythema is often mistaken for necrolytic migratory erythema and is related to Hepatitis C in viremia.
  • Despite treatment, symptoms of conditions like necrolytic migratory erythema may persist even after the primary disease is managed.